Cushing’s disease (CD) is a costly disease, both in terms of its cost to the patient-physical, emotional, and financial-and its cost to society. The costs to the patient are represented by the increased mortality risk, about three-five fold in untreated disease, and the physical costs associated with its significant comorbidities – hypertension, diabetes, cardiac disease,… Continue Reading